Statutory guidance

Formulation and finishing of pharmaceutical products: process guidance note 6/43

Regulators must use this process guidance note (PGN) to assess applications and write permits for the formulation and finishing of pharmaceutical products

• From: Department for Environment, Food & Rural Affairs, Department of the Environment (Northern Ireland), Welsh Government and The Scottish Government
• Published: 1 June 2014

Documents

Formulation and finishing of pharmaceutical products: process guidance note 6/43(11)

PDF, 1.1 MB, 61 pages

Details

Local authority regulators can be:

• district councils, borough councils, unitary councils or port health authorities in England and Wales
• the Scottish Environment Protection Agency in Scotland
• district councils or the Northern Ireland Environment Agency in Northern Ireland

This PGN includes:

• air emission limits
• emission monitoring methods
• best available techniques to control air emissions

Formulation and finishing of pharmaceutical products is a ‘Part B’ activity under the local authority pollution prevention and control (LAPPC) regime.

Published 1 June 2014